RabenMS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab1958; 18: 901–903
2.
GibbsCJJnrJoyAHeffnerR. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med1985; 313: 734–738
3.
Powell-JacksonJWellerROKennedyPPreeceMAWhitcombeEMNewsome-DavisJ.Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet1985; ii: 244–246
4.
Editorial JAMA1985; 254: 475–480
5.
TannerJMWhitehouseRHHughesPCRVinceFP. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's Syndrome and other complaints. Arch Dis Child1971; 46: 745–782
6.
RudmanDKutnerMHBlackstonRDCushmanRABainRPPattersonJH. Children with normal variant short stature: Treatment with human growth hormone for six months. N Engel J Med1981; 305: 123–131
7.
HayekAPeakeGT. Growth and somatomedin — C responses to growth hormone in dwarf children. J Pediatr1981; 99: 868–872
LenkoHLLeistiSPerheentupaJ.The efficacy of growth hormone in different types of growth failure: Analysis of 101 cases. Eur J Pediatr1982; 138: 241–249
10.
SpiliotisBEAugustGPHungWSonisWMendelsonWBercuBB. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA1984; 251; 2223–2230
11.
Van VlietGStyneDMKaplanSLGrumbackMM. Growth hormone treatment for short stature. N Engl J Med1983; 309: 1016–1022
12.
Albertsson-WiklandKIsakssonORosbergSWestphalO.Secretory pattern of growth hormone in children of different growth rates. Acta Endocrinol (Suppl)1983; 256: 72
13.
ZadikZChalewSAKowarskiAA. Do short children secrete insufficient growth hormone?Pediatrics1985; 76: 355–360
14.
BercuBBShulmanDRootAWSpiliotisBE. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metal1986; 63: 709–715
15.
TanBCKunaratnamN.Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clin Radiol1966; 17: 302–304
16.
BlaatJBercuBBGillinJCMendelsonWBPoplackDG. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukaemia. J Pediatr1984; 104: 132–186
17.
RomsheCAZipfWBMiserA. Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation — Associated short stature. J Pediatr1984; 104: 177–181
RosenfeldRGHintzRLJohansonAJ. Results from the first 2 years of a clinical trial with recombinant DNA — Derived human growth hormone (Somatrem) in Turner's syndrome. Acta Paediatr Scand (Suppl), 1987; 331: 59–66
20.
GuilleminRBrazeauPBohlenP. Growth hormone-releasing factor from a human pancreatic tumour than caused acromegaly. Science1982; 219: 585–587
21.
RivierJSpiessJThornerMValeW.Characterisation of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature1982; 300: 276–278
22.
BorgesJLCGelatoMCRogolAD. Effects of human pancreatic tumour growth hormone-releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet1983; ii: 119–124
23.
SchriockEALustigRHRosenthalSMKaplanSIGrumbackMM. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiencies; evidence of hypothalmic GRH deficiency. J Clin Endocrinol Metab1984; 58: 1043–1049
24.
RogolADBlizzardRMJohansonAJ. Growth hormone release in response to human pancreatic tumour growth hormone-releasing hormone — 40 in children with short stature. J Clin Endocrinol Metab1984; 59: 580–586
25.
TakanoKHizukaNShizumeK. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. J. Clinol Endocrinol Metab1984; 58: 236–241
26.
GrossmanASavageMOBlacklayA. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. Horm Res1985; 22: 52–57
27.
Evain-BrionD.Usefulness of a single IV injection of GRF 1–44 NH2 in assessment of somatotrophic function in children with growth failure. J Endocrinol Invest1985; 8 (Suppl 3): 68
28.
RossRJMRoddaCGrossmanA. Subcutaneous growth hormone-releasing hormone (1–29) NH2 in growth hormone deficient children. Neuroendocrine perspectivesVol 5Amsterdam, New York, Oxford: Elsevier1986; 137–142
29.
RossRJMBorgesFGrossmanA. Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone; evidence of a direct effect of growth hormone. Clin Endocrinol1987; 26: 117–123
30.
Albertsson-WiklandKWestphalOWestgrenU.Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand1986; 75: 89–97